These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 35152091
1. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases. Hu L, Yang H, Yu T, Chen F, Liu R, Xue S, Zhang S, Mao W, Ji C, Wang H, Xie H. Eur J Med Chem; 2022 Mar 15; 232():114174. PubMed ID: 35152091 [Abstract] [Full Text] [Related]
2. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design. Linciano P, Cendron L, Gianquinto E, Spyrakis F, Tondi D. ACS Infect Dis; 2019 Jan 11; 5(1):9-34. PubMed ID: 30421910 [Abstract] [Full Text] [Related]
3. A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc. Jackson AC, Zaengle-Barone JM, Puccio EA, Franz KJ. ACS Infect Dis; 2020 May 08; 6(5):1264-1272. PubMed ID: 32298084 [Abstract] [Full Text] [Related]
4. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1). Nagulapalli Venkata KC, Ellebrecht M, Tripathi SK. Eur J Med Chem; 2021 Dec 05; 225():113747. PubMed ID: 34391033 [Abstract] [Full Text] [Related]
5. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach. Muteeb G, Alsultan A, Farhan M, Aatif M. Molecules; 2022 Feb 14; 27(4):. PubMed ID: 35209073 [Abstract] [Full Text] [Related]
6. Real-Time Monitoring of NDM-1 Activity in Live Bacterial Cells by Isothermal Titration Calorimetry: A New Approach To Measure Inhibition of Antibiotic-Resistant Bacteria. Zhang YJ, Wang WM, Oelschlaeger P, Chen C, Lei JE, Lv M, Yang KW. ACS Infect Dis; 2018 Dec 14; 4(12):1671-1678. PubMed ID: 30383355 [Abstract] [Full Text] [Related]
7. Recent research and development of NDM-1 inhibitors. Wang T, Xu K, Zhao L, Tong R, Xiong L, Shi J. Eur J Med Chem; 2021 Nov 05; 223():113667. PubMed ID: 34225181 [Abstract] [Full Text] [Related]
8. Aurones and derivatives as promising New Delhi metallo-β-lactamase (NDM-1) inhibitors. Caburet J, Verdirosa F, Moretti M, Roulier B, Simoncelli G, Haudecoeur R, Ghazi S, Jamet H, Docquier JD, Boucherle B, Peuchmaur M. Bioorg Med Chem; 2024 Jan 01; 97():117559. PubMed ID: 38109811 [Abstract] [Full Text] [Related]
9. Identification of a Potential Inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) Using In Silico and In Vitro Approaches. Muteeb G, Rehman MT, AlAjmi MF, Aatif M, Farhan M, Shafi S. Molecules; 2022 Sep 13; 27(18):. PubMed ID: 36144666 [Abstract] [Full Text] [Related]
10. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose. Kondratieva A, Palica K, Frøhlich C, Hovd RR, Leiros HS, Erdelyi M, Bayer A. Eur J Med Chem; 2024 Feb 15; 266():116140. PubMed ID: 38242072 [Abstract] [Full Text] [Related]
11. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria. Guo Y, Liu H, Yang M, Ding R, Gao Y, Niu X, Deng X, Wang J, Feng H, Qiu J. Br J Pharmacol; 2024 Jan 15; 181(1):54-69. PubMed ID: 37539785 [Abstract] [Full Text] [Related]
12. Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance. Zhang J, Wang S, Wei Q, Guo Q, Bai Y, Yang S, Song F, Zhang L, Lei X. Bioorg Med Chem; 2017 Oct 01; 25(19):5133-5141. PubMed ID: 28784300 [Abstract] [Full Text] [Related]
13. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1. Rehman MT, AlAjmi MF, Hussain A, Rather GM, Khan MA. Int J Mol Sci; 2019 Feb 14; 20(4):. PubMed ID: 30769822 [Abstract] [Full Text] [Related]
14. Thiosemicarbazones exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1). Ge Y, Kang PW, Li JQ, Gao H, Zhai L, Sun LY, Chen C, Yang KW. J Antibiot (Tokyo); 2021 Sep 14; 74(9):574-579. PubMed ID: 34234284 [Abstract] [Full Text] [Related]
15. Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors. Ma G, Wang S, Wu K, Zhang W, Ahmad A, Hao Q, Lei X, Zhang H. Bioorg Med Chem; 2021 Jan 01; 29():115902. PubMed ID: 33302045 [Abstract] [Full Text] [Related]
16. Potential Inhibitors Against NDM-1 Type Metallo-β-Lactamases: An Overview. Sharma S, Sharma S, Singh PP, Khan IA. Microb Drug Resist; 2020 Dec 01; 26(12):1568-1588. PubMed ID: 32486911 [Abstract] [Full Text] [Related]
17. Phenotypic and in silico studies for a series of synthetic thiosemicarbazones as New Delhi metallo-beta-lactamase carbapenemase inhibitors. Moreira JS, Galvão DS, Xavier CFC, Cunha S, Pita SSDR, Reis JN, Freitas HF. J Biomol Struct Dyn; 2022 Dec 01; 40(24):14223-14235. PubMed ID: 34766882 [Abstract] [Full Text] [Related]
18. Novel Cephalosporin Conjugates Display Potent and Selective Inhibition of Imipenemase-Type Metallo-β-Lactamases. Tehrani KHME, Wade N, Mashayekhi V, Brüchle NC, Jespers W, Voskuil K, Pesce D, van Haren MJ, van Westen GJP, Martin NI. J Med Chem; 2021 Jul 08; 64(13):9141-9151. PubMed ID: 34182755 [Abstract] [Full Text] [Related]
19. New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition. King DT, Worrall LJ, Gruninger R, Strynadka NC. J Am Chem Soc; 2012 Jul 18; 134(28):11362-5. PubMed ID: 22713171 [Abstract] [Full Text] [Related]
20. A close look onto structural models and primary ligands of metallo-β-lactamases. Raczynska JE, Shabalin IG, Minor W, Wlodawer A, Jaskolski M. Drug Resist Updat; 2018 Sep 18; 40():1-12. PubMed ID: 30466711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]